416 Results

People

  1. Cordon-Cardo
    Cordon-Cardo
  2. Antonescu
    Antonescu
  3. Koche
    Koche
  4. Chaganti
    Chaganti
  5. Morris
    Morris
  6. Cheung
    Cheung
  7. Fair
    Fair
  8. Ladanyi
    Ladanyi
  9. Offit
    Offit
  10. Scheinberg
    Scheinberg

Groups

  1. Department of Medicine (132)
  2. GSK Faculty (123)
  3. Solid Tumor Oncology Division (85)
  4. Sloan Kettering Institute Faculty (83)
  5. Sloan Kettering Institute Postdocs (68)
  6. Department of Pathology and Laboratory Medicine (66)
  7. Center for Hematologic Malignancies (51)
  8. Hematologic Malignancies, Division of (50)
  9. Tow Center for Developmental Oncology (TCDO) (47)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (46)
  1. "expression"
Formats
  1. Journal Article (379)
  2. Meeting Abstract (18)
  3. Review (8)
  4. Conference Paper (6)
  5. Book Section (3)
  6. Research Letter (2)
Groups
  1. Department of Medicine (132)
  2. GSK Faculty (123)
  3. Solid Tumor Oncology Division (85)
  4. Sloan Kettering Institute Faculty (83)
  5. Sloan Kettering Institute Postdocs (68)
  6. Department of Pathology and Laboratory Medicine (66)

More Groups

People
  1. Carlos Cordon-Cardo (10)
  2. Cristina Antonescu (8)
  3. Jedd Wolchok (8)
  4. Richard Koche (8)
  5. Taha Merghoub (8)
  6. Michael Morris (7)

More People

Years
  1. 2025 (13)
  2. 2024 (13)
  3. 2023 (17)
  4. 2022 (34)
  5. 2021 (20)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Blood (22)
  3. Clinical Cancer Research (15)
  4. Cancer Research (13)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (11)
  6. Cancer Discovery (10)

More Publications

Publishers
  1. American Association for Cancer Research (64)
  2. Nature Publishing Group (40)
  3. American Society of Clinical Oncology (35)
  4. Lippincott Williams & Wilkins (27)
  5. American Society of Hematology (25)
  6. Elsevier Inc. (19)

More Publishers

Results (416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics
    Journal Article

    Kumthekar, P. U.; Avram, M. J.; Lassman, A. B.; Lin, N. U.; Lee, E.; Grimm, S. A.; Schwartz, M.; Bell Burdett, K. L.; Lukas, R. V.; Dixit, K.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells
    Journal Article

    Maura, F.; Ziccheddu, B.; Xiang, J. Z.; Bhinder, B.; Rosiene, J.; Abascal, F.; Maclachlan, K. H.; Eng, K. W.; Uppal, M.; He, F.; more...
    Blood Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Loss of CDKN2A/B is a molecular marker of high-grade histology and is associated with aggressive behavior in acinic cell carcinoma
    Journal Article

    Dogan, S.; Xu, B.; Rana, S.; Chen, H.; Ghossein, R. A.; Berger, M. F.; Ho, A. L.; Katabi, N.
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Immune checkpoint blockade outcome in small-cell lung cancer and its relationship with retinoblastoma mutation status and function
    Journal Article

    Dowlati, A.; Abbas, A.; Chan, T.; Henick, B.; Wang, X.; Doshi, P.; Fu, P.; Patel, J.; Kuo, F.; Chang, H.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Germline SMARCA4 deletion as a driver of uterine cancer: An atypical presentation
    Journal Article

    Navitski, A.; Al-Rawi, D. H.; Makker, V.; Weigelt, B.; Zamarin, D.; Liu, Y.; Arnold, A. G.; Chui, M. H.; Mandelker, D. L.; Walsh, M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Signal-regulatory protein alpha (SIRPα) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • CD133 as a biomarker for an autoantibody-to-immunoPET paradigm for the early detection of small cell lung cancer
    Journal Article

    Kunihiro, A. G.; Sarrett, S. M.; Lastwika, K. J.; Solan, J. L.; Pisarenko, T.; Keinänen, O.; Rodriguez, C.; Taverne, L. R.; Fitzpatrick, A. L.; Li, C. I.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
    Journal Article

    Chatila, W. K.; Kim, J. K.; Walch, H.; Marco, M. R.; Chen, C. T.; Wu, F.; Omer, D. M.; Khalil, D. N.; Ganesh, K.; Qu, X.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide for patients with androgen receptor-positive salivary gland cancers (Alliance A091404)
    Journal Article

    Ho, A. L.; Foster, N. R.; Zoroufy, A. J.; Campbell, J. D.; Worden, F.; Price, K.; Adkins, D.; Bowles, D. W.; Kang, H. Y. S.; Burtness, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save